Hybio Pharmaceutical Co., Ltd. (SZSE:300199) agreed to acquire 10.81% stake in Hybio Biotechnology (Dali) Co., Ltd. from Dazhong Transportation (Group) Co., Ltd. (SHSE:600611) for CNY 20 million on May 10, 2022. After the repurchase is completed, Hybio Pharmaceutical will hold 69.22% of Hybio Biotechnology. As on December 31, 2021, Hybio Pharmaceutical reported total assets of approximately CNY 110 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 CNY | -6.03% | +7.71% | -10.46% |
1st Jan change | Capi. | |
---|---|---|
-10.46% | 1.48B | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 300199 Stock
- News Hybio Pharmaceutical Co., Ltd.
- Hybio Pharmaceutical Co., Ltd. agreed to acquire 10.81% stake in Hybio Biotechnology Co., Ltd. from Dazhong Transportation Co., Ltd. for CNY 20 million.